Bupivacaine and Kaltostat reduces post-operative donor site pain.
A prospective double blind controlled trial was carried out to examine the differences in post-operative split skin graft donor site pain between sites dressed with three differently treated types of dressing; a dry calcium alginate dressing (Kaltostat Britcair), a saline moistened Kaltostat dressing and a bupivacaine hydrochloride (0.5%) moistened Kaltostat dressing. There was a significant reduction in post-operative pain in the Kaltostat and bupivacaine group (group 3) at 24 and 48 h when compared to the other two groups (p < 0.04). There was no difference in ease of removal of dressings or the quality of wound healing on day 10 between the three groups. This study demonstrates a significant reduction in post-operative pain in bupivacaine soaked Kaltostat without reducing the beneficial effects of Kaltostat on donor site healing and we recommend its use in clinical practice
|Title:||Bupivacaine and Kaltostat reduces post-operative donor site pain|
|Additional information:||DA - 19931220IS - 0007-1226 (Print)LA - engPT - Clinical TrialPT - Comparative StudyPT - Journal ArticlePT - Randomized Controlled TrialRN - 0 (Alginates)RN - 0 (Hemostatics)RN - 0 (Hexuronic Acids)RN - 2180-92-9 (Bupivacaine)RN - 576-37-4 (Glucuronic Acid)RN - 7647-14-5 (Sodium Chloride)RN - 9005-32-7 (alginic acid)SB - IM|
|Keywords:||Acids, Adult, Alginates, Bandages, Bupivacaine, Double-Blind Method, Female, Glucuronic Acid, Hemostatics, Hexuronic Acids, Humans, Ireland, Male, Middle Aged, Pain Measurement, Pain, Postoperative, physiology, prevention & control, Prospective Studies, Skin, Skin Transplantation, Sodium Chloride, surgery, therapeutic use, Wound Healing|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
Archive Staff Only